By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...

XINTAI, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global pharmaceutical packaging ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

Tens of thousands of cholesterol medication bottles are being recalled nationwide due to manufacturing issues that could ...

Eli Lilly to build $3.5 billion Lehigh Valley complex as demand for weight loss drugs grows ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's competitive position.

FDA PreCheck pilot aims to speed U.S. pharma plant construction and approvals for critical medicines with earlier feedback.

A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of ...

The plant will help make Lilly's experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial.

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...